Happy 9th Anniversary
@Verily
!! A fabulous celebration packed with family fun activities and project showcases to name a few of the engaging events here onsite in San Bruno today.
@bongofreek
@CaelaShay
Excited to share that our work exploring LLM-generated labels for clinical trial digitization was accepted at MLHC 2024. Lack of expert annotation is a big bottleneck in applying ML to healthcare problems. 1/n
Next week at
@mlforhc
MLHC 2024, we’ll present a paper on how Verily researchers fine-tuned the PaLM-2
#AI
model using Gemini-pro 1.0-generated high confidence labels, showing the promise of optimizing
#LLM
performance to digitize
#ClinicalTrial
protocols.
Beauty is truth, truth beauty
Thought provoking opening lecture on digital health: making sure the data used to generate AI tools have diverse populations, diverse voices, patient led
Go beyond the restrictive bounds of clinical trials, our silos
@Verily
#ASCOBT24
Great opening Keynote by Dr Trister!
@Verily
#ASCOBT24
So many take home messages:
Pictures speak volumes…
Still… an uncertain time ahead for
#AI
in healthcare and dialogues and collaborations between public private partnerships are crucial!
In a new paper in
@JAMA_current
, clinical trial experts, including from Verily, explore how to overcome limitations in accessing, acquiring and using data in
#ClinicalTrials
, and propose a modern data infrastructure to better connect research and care.
Verily Numetric Retinal Camera will be used in retinal image data collection for the
@NatEyeInstitute
’s eyeGENE® registry due to its image quality, ease-of-use and portability. The initiative aims to advance research for rare inherited
#EyeDiseases
.
Key takeaway from the DiME-
@US_FDA
workshop 👉 medical device companies are incorporating patient-generated
#HealthData
into their product development, but with room to do better.
ICYMI, watch the recording to hear developers’ and patients’ perspective.
Our new cardiometabolic care solution, Verily Lightpath, will help members meet and maintain
#cardiometabolic
health goals through access to an
#AI
helper, designed to inform personal pathways. It will be available for open enrollment in early 2026.
The most potential for
#AIinHealthcare
is in improving, not replacing, what physicians can do for a patient, says Andrew Trister, our Chief Medical and Scientific Officer. He’ll go in depth about this in his keynote address at
@ASCO
#ASCOBT24
on 8/8.
@Verily
,
@Google
's life sciences sister company, has announced its corporate headquarters move to Dallas.
The Dallas Region continues to stand out as a premier, central hub for life sciences.
Read more about the announcement here:
Verily Lightpath Metabolic* programs for
#HealthPlans
will be a dynamic and personalized approach to help manage
#diabetes
, obesity, hypertension and more. Explore AI-powered metabolic care, backed by deep clinical expertise:
*To be available early 2026